Treatment of hypothyroidism in elderly patients and in patients with cardiac disease

Thyroid

Volumn 17, Issue 7, 2007, Pages 619-624

  Feldt Rasmussen, Ulla ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; LEVOTHYROXINE; LIOTHYRONINE; PLACEBO; THYROTROPIN; THYROXINE;

AGED; ATHEROSCLEROSIS; BASAL METABOLIC RATE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THYROID FUNCTION TEST; UNSTABLE ANGINA PECTORIS;

AGED; HEART DISEASES; HUMANS; HYPOTHYROIDISM; SAFETY; THYROXINE;

EID: 34548147425     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0033     Document Type: Review

References (42)

1. Klein I, Ojamaa K 1992 Cardiovascular manifestations of endocrine disease J Clin Endocrinol Metab 75:339-342.
2. Streeten DH, Anderson GH Jr, Howland T, Chiang R, Smulyan H 1988 Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11:78-83.
3. Friis T, Pedersen LR 1987 Serum lipids in hyper- and hypothyroidism before and after treatment. Clin Chim Acta 162:155-163.
4. Dernellis J, Panaretou M 2002 Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J 143:718-724.
5. Obuobie K, Smith J, Evans LM, Davies JJS, Lazarus JH 2002 Increased arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 87:4662-4666.
6. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Subclinical hypothyroidism and cardiac function. Thyroid 12:505-510.
7. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ 2004 Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 291:228-238.
8. Klein I, Ojamaa K 2000 The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD (eds) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp 777-782.
9. Kohno A, Hara Y 2001 Severe myocardial ischemia following hormone replacement in two cases of hypothyroidism with normal coronary arteriograms. Endocr J 48:565-572.
10. Fazio S, Palmieri EA, Lombardi G, Biondi B 2004 Effects of thyroid hormone on the cardiovascular system. Recent Progr Horm Res 59:31-50.
11. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10 year cohort study. Lancet 358:861-865.
12. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Rodgers H, Tunbridge F, Young ET 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6:155-160.
13. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older age. JAMA 295:1033-1041.
14. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JCM 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Int Med 132:270-278.
15. Singer RB 2006 Mortality in a complete 4-year follow up of 85-year-old residents of Leiden, classified by serum level of thyrotropin and thyroxine. J Insur Med 38:14-19.
16. Gussekloo J, von Exel E, de Craen AJM, Meinders AE, Fröhlich M, Westendorp RGJ 2004 Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591-2599.
17. Van den Beld AW, Visser TJ, Fedders RA, Grobbel DE, Lamberts SWJ 2005 Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 90:6403-6409.
18. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467-2472.
19. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashozawa K, Yokoyama N, Maeda R, Nagataki S, Egichi K 2004 Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89:3365-3370.
20. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC 2005 Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Int Med 165:2460-2466.
21. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC 2006 Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 119:541-551.
22. Boelaert K, Franklyn JA 2005 Thyroid hormone in health and disease. J Endocrinol 187:1-15.
23. Petersen K, Bengtsson C, Lapidus L, Lindstedt G, Nyström E 1990 Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med 150:2077-2081.
24. Flynn RWV, MacDonald TM, Jung RT, Morris AD, Leese GP 2006 Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159-2164.
25. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double-blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 86:4860-4866.
26. Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ 1997 Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 82:771-776.
27. Caraccio N, Ferrannini E, Monzani F 2002 Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomised placebo-controlled study. J Clin Endocrinol Metab 87:1533-1538.
28. Nyström E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G 1988 A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 29:63-75.
29. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC 1984 L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 101:18-24.
30. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L, Carbotte R 1996 Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 11:744-749.
31. Dagre AG, Lekakis JP, Papaioannou TG, Papamichael CM, Koutras DA, Stamatelopoulos SF, Alevizaki M 2005 Arterial stiffness is increased in subjects with hypothyroidism. Int J Cardiol 103:1-6.
32. Hamano K, Inoue M 2005 Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr J 52:95-101.
33. Aronow WS 1995 The heart and thyroid disease. Clin Geriatr Med 11:219-229.
34. Thyroid Disease Manager. Available at www.thyroidmanager.org
35. Wiersinga WM 2001 Thyroid hormone replacement therapy. Horm Res 56:74-81.
36. Keating FR Jr, Parkin TW, Selby JB, Dickinson LS 1961 Treatment of heart disease associated with myxedema. Progr Cardiovasc Dis 3:364-381.
37. Syed AU, El Watidy AF, Akhlaque NB, Wahba A, El Oakley RM, Imran K, Al Bukhari EA, Al Fagih MR 2002 Coronary bypass surgery in patients on thyroxine replacement therapy. Asian Cardiovasc Thorac Ann 10:107-110.
38. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522-1527.
39. Wolff J, Chaikoff IL, et al. 1949 The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid. Endocrinology 45:504-513.
40. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S 2000 Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85:159-164.
41. Botella-Carretero JI, Gomez-Bueno M, Barrios V, Caballero C, Garcia-Robles R, Sancho J, Escobar-Morreale HF 2004 Chronic thyrotropin suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 11:345-356.
42. Watt T, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedus L, Bjorner JB, Feldt-Rasmussen U 2006 Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 154:501-510.